Quantcast
Last updated on April 16, 2014 at 12:22 EDT

Latest Gene therapy Stories

2012-06-18 11:20:31

Newly clarified function of 'indirect pathways' from brain to spinal motor neurons, controlling dexterous hand movements by newly developed 'the double viral vector transfection technique' The collaborative research team led by Professor Tadashi ISA, Project Assistant Professor Masaharu KINOSHITA from The National Institute for Physiological Sciences, The National Institutes of Natural Sciences and Fukushima Medical University and Kyoto University, developed "the double viral vector...

2012-06-18 02:28:33

SAN DIEGO, June 18, 2012 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it has received a Notice of Allowance from the European Patent Office (EPO) for claims that cover MYDICAR, Celladon's first in class drug under clinical evaluation for advanced heart failure. The patent to be issued from this allowed patent application, titled "Extended...

2012-06-18 02:28:25

AMSTERDAM, The Netherlands, June 18, 2012 /PRNewswire/ -- uniQure, a leader in the field of human gene therapy, announced today the extension of its collaboration with Protein Sciences Corporation ("Protein Sciences") for the exclusive use of Protein Sciences' expresSF+(R) (SF+) insect cell line in uniQure's AAV gene therapy programs for three specific disease indications. uniQure has the option to extend this exclusivity further into additional indications in the future....

2012-06-11 23:00:42

HUNTINGTON´S DISEASE, for the FIRST time in history was treated in March 2012 by Dr.´s Feinerman and Paino in our state of the art clinic in Lima, Peru. Two sisters with this debilitating disease will be followed over the next year after a very successful treatment. You can follow the progress and see other testimonials on our website, http://www.stemcellregenmed.com Aventura, North Miami, Florida (PRWEB) June 11, 2012 In a time of such an amazing biotechnology medical era in...

2012-06-05 02:27:34

SAN DIEGO, June 5, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced today that the Company has entered into an exclusive cGMP manufacturing agreement with VGXI Inc. (VGXI) for the production of interleukin-12 plasmid DNA (DNA IL-12). Financial terms of the agreement were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) Punit...

2012-06-01 09:56:20

New Weizmann Institute technology speeds up DNA “rewriting” and measures the effects of the changes in living cells Our ability to “read” DNA has made tremendous progress in the past few decades, but the ability to understand and alter the genetic code, that is, to “rewrite” the DNA-encoded instructions, has lagged behind. A new Weizmann Institute study advances our understanding of the genetic code: It proposes a way of effectively introducing numerous...

2012-05-25 09:44:40

The scientific and technological literature is abuzz with nanotechnology and its manufacturing and medical applications. But it is in an area with a less glitzy aura-plant sciences-where nanotechnology advancements are contributing dramatically to agriculture. Researchers at Iowa State University have now demonstrated the ability to deliver proteins and DNA into plant cells, simultaneously. This is important because it now opens up opportunities for more sophisticated and targeted plant...

2012-05-24 21:23:11

Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene. Traditional treatment options, such as enzyme replacement therapy, are of limited efficacy, but bone marrow transplant from a compatible donor leads to a better response. A recent clinical...

2012-05-21 02:25:02

RICHMOND, Calif., May 21, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics® for HIV/AIDS, monogenic diseases and stem cell applications, were described in twelve presentations given by Sangamo scientists and collaborators at the 15th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). The meeting was held in Philadelphia...

2012-05-16 06:27:09

SAN FRANCISCO and HOUSTON, May 16, 2012 /PRNewswire/ -- Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery vehicles for the...